Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest myopathy Stories

2013-12-18 13:34:23

A new gene mutation which will help doctors give a more accurate diagnosis of a particular type of brain and muscle disease in children has been discovered for the first time by University of Leeds experts. Mitochondrial myopathy, as it is known, causes muscle weakness, movement problems and learning difficulties and affects more than 70,000 people in the UK. For the first time, mutations in a particular gene, MICU1, have been linked to myopathy. The discovery gives a better...

2013-10-23 23:02:23

Seminar is open to the public on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, LA from 10 a.m. – 2 p.m. Shreveport, LA (PRWEB) October 23, 2013 The Muscular Dystrophy Association invites residents in the Ark-La-Tex area to fight back against muscle disease by participating in the "Living with a Muscle Disease" seminar on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, La. from 10 a.m. – 2 p.m. "Living with a Muscle Disease"...

2013-10-04 23:21:56

d’Oliveira & Associates has posted a new infographic which provides a list of side effects and timeline of events. The law firm works with some of the more experienced Zocor lawyers who handle these cases. (PRWEB) October 04, 2013 Zocor (simvastatin) helps control high cholesterol when combined with a healthy diet and exercise. The FDA approved this medicine in December 1991. It has also been approved in combination with drugs like Januvia (Juvisync) and Zetia (Vytorin). On March...

2013-05-30 23:02:45

The Muscular Dystrophy Association has awarded Valerion Therapeutics $1,195,762 to continue development of an experimental cell-penetrating treatment that may represent a unique approach to treating myotubular myopathy (MTM). Tucson, Ariz. (PRWEB) May 30, 2013 The Muscular Dystrophy Association has awarded Valerion Therapeutics $1,195,762 to continue development of an experimental cell-penetrating treatment that may represent a unique approach to treating myotubular myopathy (MTM). The...

2013-04-13 23:01:48

The Firm is currently investigating Zocor lawsuits on behalf of individuals who suffered serious Zocor side effects. New York, New York (PRWEB) April 13, 2013 Bernstein Liebhard LLP notes that a new study is raising additional concerns about possible Zocor side effects, specifically kidney damage. The study, which was published online on March 19 in the British Medical Journal, found that patients treated with higher doses of statins like Zocor were 34% more likely to be hospitalized...

2013-03-20 12:26:48

SARM Could Represent a New Category of Therapy for Duchenne Muscular Dystrophy, Potential for Other Neuromuscular Diseases CAMBRIDGE, Mass., March 20, 2013 /PRNewswire/ -- DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy (DMD), announced today that it is developing a SARM drug candidate obtained from Belgium-based Galapagos NV. In early studies, the drug candidate, renamed DT-200, demonstrated...

2012-12-17 16:44:17

-Myopathy refers to a disease characterized by muscular weakness and wasting. -Vitamin D deficiency is a well-recognized cause of myopathy, and excessive drinking is often associated with low or subnormal levels of vitamin D. -A new review indicates that vitamin D deficiency might partly explain the occurrence of the frequently observed myopathy in chronic alcoholism. Myopathy refers to a muscular disease in which muscle fibers do not function, resulting in muscular weakness and wasting....

2012-10-03 10:06:21

Preliminary research finds that for patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain, use of the anti-arrhythmic medication mexiletine resulted in improvement in patient-reported stiffness, according to a preliminary study in the October 3 issue of JAMA. Data on treatment of NDMs are largely anecdotal, consisting of case series and a single-blind, controlled trials of several medications including...

2012-09-13 02:26:49

ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis. "Questcor is very pleased to be able to make this commitment to The Myositis Association and the dermatomyositis and polymyositis communities," said Steve Cartt, Chief Operating Officer of Questcor. "Further research into these...

2012-06-14 10:23:03

ANAHEIM, Calif., June 14, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced key elements of the Company's initial commercialization plans for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of rheumatology-related indications already included on the FDA-approved package insert for Acthar. Acthar is indicated for multiple FDA-approved rheumatology-related conditions, including its use as adjunctive therapy in psoriatic arthritis,...